← Evidence map

ArticleClinical kidney journal2026

Anti-PLA2R positivity does not exclude malignancy in membranous nephropathy: lessons from the course after tumor treatment.

Saide Elif Güllülü Boz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Anti-PLA2R positivity does not exclude malignancy in membranous nephropathy: lessons from the course after tumor treatment. | OpenQuestion